Grace Therapeutics, Inc. (GRCE)

3.65 +0.08 (+2.24%) USD  |  NASDAQ  |  Jan 21, 15:41
More

Grace Therapeutics Preferred Stock (Quarterly)

Preferred Stock (Quarterly) Chart

View Preferred Stock (Quarterly) for GRCE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock (Quarterly) Range, Past 5 Years

View Preferred Stock (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock (Quarterly) Benchmarks

View Preferred Stock (Quarterly) Benchmarks
Start Trial
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade
NanoViricides, Inc. Upgrade